N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
US9139525B2 · kind B2 · utility
19Cited by
6References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 11, 2008 |
| Grant date | Sep 22, 2015 |
| Priority date | — |
| Expiry date | Aug 21, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound having the general formulawherein A is selected from the group consisting ofto the formation of a compound of the general formula (1)and a compound of the general formula (2)respectively, and pharmaceutically acceptable salts thereof, wherein The invention also relates to a pharmaceutical preparation containing said compound, the use of said compound for the manufacture of a pharmaceutical composition and a method for the treatment of a disorder in the central nervous system of a patient using said compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.